PitchBook-2025年三季度卫生技术公共报表和评估指南（英）-2025
EMERGING TECH RESEARCH PitchBook Data, Inc. Nizar Tarhuni Executive Vice President of Research
报告摘要
EMERGING TECH RESEARCH PitchBook Data, Inc. Nizar Tarhuni Executive Vice President of Research
核心要点
- 1 week
- 30 days
- 90 days
报告信息
- 文件全名
- 《PitchBook-2025年三季度卫生技术公共报表和评估指南（英）-2025-8页.pdf》
- 适合读者
- 核心数据
- performance in the EHRs & clinical information segment has been particularly weak, with share prices down 11% on average so far
- in 2025. The virtual care & RPM segment has also seen negative returns on average, down 3% YTD. However, recent listings by
- underperformance trend this year include iRhythm Technologies, up 92%, Doximity, up 37%, and Sectra, up 30%.
- • Claritev surges over 300%: After beating Q2 revenue expectations, Claritev’s stock soared, ending Q3 up 310% on the year and
- nearly 30% when Novo Nordisk abruptly called off the deal. Yet investor optimism has returned—shares are up 125% YTD and
- 核心议题
常见问题
《PitchBook-2025年三季度卫生技术公共报表和评估指南（英）-2025》主要包含哪些内容?
EMERGING TECH RESEARCH PitchBook Data, Inc. Nizar Tarhuni Executive Vice President of Research核心数据:performance in the EHRs & clinical information segment has been particularly weak, with share prices down 11% on average so far;in 2025. The virtual care & RPM segment has also seen negative returns on average, down 3% YTD. However, recent listings by;underperformance trend this year include iRhythm Technologies, up 92%, Doximity, up 37%, and Sectra, up 30%.。
这份报告由哪家机构发布?
本报告由PitchBook发布,发布于 2025 年。
这份报告覆盖哪一年、篇幅多大?
覆盖 2025 年,全文共 8 页。
这份报告是免费的吗?如何获取?
本报告免费查阅,登录资料宝后即可在线获取完整内容。
这份报告适合哪些读者?
适合战略规划、行业研究员等读者参考。
报告涉及哪些关键议题?
重点分析了管理咨询等议题。
继续阅读
查看全部 →